| Financial Year |
March 31 2023 |
| Monetary Funds |
2,430,119,239.70 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
1,317,936,167.47 |
| Advances to Suppliers |
45,747,018.66 |
| Other Receivables |
55,270,340.19 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,179,948,838.89 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
44,917,609.08 |
| Total Current Assets |
5,847,428,273.50 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,825,353,599.67 |
| Investment Properties |
3,897,795.60 |
| Fixed Assetes |
2,561,491,245.46 |
| Under-construction Projects |
603,789,893.18 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
384,862,243.75 |
| R&D expenses |
-- |
| Goodwill |
184,722,901.05 |
| Long-Term Deferred and Prepaid Expenses |
37,706,774.84 |
| Deferred Income Tax Assets |
55,976,389.93 |
| Other Non-Current Assets |
5,398,767.93 |
| Sub-Total of Non-Current Assets |
5,925,844,596.80 |
| Total Assets |
11,773,272,870.30 |
| Short-Term Loans |
1,133,099,718.06 |
| Trading Financial liabilities |
-- |
| Notes Payable |
49,142,381.98 |
| Accounts Payable |
621,108,612.57 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
128,981,567.47 |
| Taxes Payable |
176,253,981.97 |
| Interest Payable |
-- |
| Dividend Payable |
14,275,997.02 |
| Other payables |
1,046,434,794.14 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
134,313,266.68 |
| Other Current Liabilities |
3,512,122.94 |
| Sub-Total of Current Liabilities |
3,323,172,477.80 |
| Long-term Loans |
370,452,731.38 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
924,080.06 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
326,190,772.88 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
851,206,020.52 |
| Total Liabilities |
4,174,378,498.32 |
| Paid-In Capital(Or Share Stock) |
2,570,037,319.00 |
| Capital Surplus |
156,736,583.56 |
| Surplus Reserve |
611,518,719.01 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,844,356,137.14 |
| Minority Stockholder's Interest |
416,146,817.51 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,182,747,554.47 |
| Owner's Equity（Stockholder's Equity） |
7,598,894,371.98 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
11,773,272,870.30 |
